Vaccines

New York Governor Andrew Cuomo asked Pfizer Inc (NYSE: PFE) to sell its COVID-19 vaccine directly to New York in a letter on Monday. What Happened: The governor wrote to the New York-based pharmaceutical giant’s CEO Albert Bourla as Pfizer is not bound by supply commitments that rival Moderna...

Moderna Inc. (NASDAQ: MRNA) is planning to test the efficacy of COVID-19 vaccine booster shots a year after initial doses of the vaccine have been administered to an individual, CNBC reported Thursday. What Happened: The biotech company expects to begin the booster study in adult participants in...

Uber Inc (NYSE: UBER) and Moderna Inc (NASDAQ: MRNA) said they are collaborating on supporting the uptake of COVID-19 vaccines. What Happened: The two companies will initially work on providing accessible and “credible information” on vaccine safety through Uber’s in-app messaging...

Pfizer Inc (NYSE: PFE)/BionNTech SE (NASDAQ: BNTX) COVID-19 showed signs of working against a mutation found in two highly-contagious COVID-19 virus variants detected in the U.K. and South Africa in a laboratory study conducted by Pfizer. What Happened: These positive findings were...

The United States Food and Drug Administration warned against changing the dosing regimen, interval, or mixing of COVID-19 vaccines in a statement issued Monday. What Happened: The health agency recognized that available data indicates the use of two specified doses of the COVID-19 vaccines...

Operation Warp Speed Chief Adviser Moncef Slaoui said Sunday that Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine could be administered at half the regular volume to some people in order to bolster availability. What Happened: The chief of the government’s COVID-19 vaccine...

Some 300 million people in India are set to get the vaccine made by AstraZeneca and Oxford University. What Happened: India, which has a population of 1.35 billion people, has approved its first COVID-19 vaccine and has three more in the works. India has the second-highest number of infections...

Moderna Inc (NASDAQ: MRNA) announced a worker vaccination plan as an extra layer of COVID-19 protection for its employees in the United States on Tuesday. What Happened: The biotech company said that its coronavirus vaccine will be made available to its workers, contractors, and board members under...

Moderna Inc (NASDAQ: MRNA) has agreed to supply South Korea its COVID-19 vaccine, with doses enough for 20 million people, reports Yonhap News Agency.  What Happened: Cheong Wa Dae — the South Korean presidential office — and Moderna CEO Stephane Bancel arrived at a...

The United Kingdom could approve AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine as early as Tuesday, the Financial Times reports. What Happened: The U.K.’s Medicines and Healthcare products Regulatory Agency would give approval to the AstraZeneca-Oxford University vaccine imminently,...

AstraZeneca Plc (NASDAQ: AZN) and Russia have agreed to test a combination of their vaccines, the Associated Press reported Tuesday. What Happened: On Monday, the British drugmaker signed a memorandum of cooperation with Moscow-based research facility the Gamaleya Institute, the Russian Direct...

Pfizer Inc (NYSE: PFE) is nearing a deal with the outgoing President Donald Trump's administration to supply 100 million doses of its coronavirus vaccine to the United States, the Wall Street Journal reported Tuesday. What Happened: The U.S. government would pay Pfizer $2 billion as...

Ugur Sahin, CEO of BioNTech SE (NASDAQ: BNTX) — the German partner of Pfizer Inc (NYSE: PFE) — expressed confidence that two companies’ jointly-developed vaccine is effective against a new mutation of COVID-19, Reuters reported Monday.  What Happened: Sahin told Germany...

Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine has received the go-ahead from an advisory panel of the U.S. Food and Drug Administration, paving the way for the company to secure an emergency use authorization (EUA). What Happened: The Vaccines and Related Biological Products Advisory...

Extra doses contained in the vials of Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine do not need to be discarded, according to the United States Food and Drug Administration, Reuters reported Wednesday.  What Happened: Labeling confusion had led to hospital pharmacists discarding one in every...